Trial Profile
A comparison trial evaluating safety and efficacy of dabigatran and acenocoumarol in patients undergoing pulmonary vein antral isolation for atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Acenocoumarol
- Indications Embolism and thrombosis
- Focus Adverse reactions; Therapeutic Use
- 30 Jun 2016 New trial record